Northwire Canada EditionSunday, July 12, 2026
Northwire
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
Earnings

Vireo Growth Inc. Announces Fourth Quarter 2025 Results

VREO · Price

Executive Summary

  • Vireo Growth reported Q4 2025 GAAP revenue of $104.5 M, a 317.7% YoY increase, driven by recent acquisitions.
  • Adjusted EBITDA (non‑GAAP) rose to $29.5 M (+347% YoY); adjusted EBITDA margin improved to 28.2%.
  • The company announced pending acquisitions of Eaze, Schwazze, PharmaCann retail assets, and an MOU for Hawthorne, all expected to close in H1 2026.

Key Details

  • Financial Highlights (Q4 2025 vs Q4 2024)
  • GAAP Revenue: $104.5 M vs $25.0 M (+317.7%)
  • GAAP Gross Profit: $56.9 M vs $12.7 M (+348%) – margin 54.4% (up 380 bps)
  • Adjusted EBITDA: $29.5 M vs $6.6 M (+347%) – margin 28.2% (up 180 bps)
  • Pro‑forma Revenue (including Mergers): $104.5 M vs $82.9 M (+26.1%)

  • Sequential Q4 2025 vs Q3 2025

  • Revenue up 14.0% to $104.5 M
  • Gross profit up 52.1% to $56.9 M (margin ↑ 1,360 bps)
  • Adjusted EBITDA up 16.1% to $29.5 M

  • Cash Position – End‑quarter cash of $122.5 M, total current assets $204.1 M; liquidity sufficient for further acquisitions.

  • Pending Acquisitions (expected H1 2026)

  • PharmaCann Inc. – asset purchase; consideration ≈ $49 M in subordinate voting shares (subject to adjustments).
  • Eaze Inc. – business combination; estimated equity consideration ≈ $47 M plus potential earn‑out in shares.
  • Schwazze – acquisition announced (terms not disclosed, included in pending deals).
  • Hawthorne Gardening Co. LLC – non‑binding MOU with ScottsMiracle‑Grove.

  • Recent Completed Integrations – Integration of Deep Roots, Proper, and Wholesome completed; ERP system implemented; corporate overhead synergies realized.

  • Management Commentary – CEO John Mazarakis highlighted 11.3% same‑store sales growth (ex‑Minnesota) and 55% wholesale growth YoY; reaffirmed opportunistic acquisition strategy.

  • Balance Sheet Highlights (Dec 31 2025)

  • Total assets: $817.2 M (up from $278.9 M).
  • Cash & cash equivalents: $102.2 M (restricted cash $20.3 M).
  • Total liabilities: $509.7 M; long‑term debt $127.6 M, convertible debt $8.6 M.

  • Financing Activity (FY 2025) – Proceeds from long‑term debt $146.0 M; net cash provided by financing $18.4 M.

  • Conference Call – Management will discuss results on March 17 2026, 8:00 a.m. ET (call details provided).

Notable Quotes

“Fourth quarter performance remained in line with our expectations and reflected pro‑forma same‑store sales growth excluding Minnesota of 11.3% and wholesale growth of 55% over the prior year quarter.” – John Mazarakis, CEO


All non‑material boilerplate, forward‑looking disclaimer text, and “About” sections have been omitted for brevity.

Read the original news release →

More from Vireo Growth Inc.